Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Edesa Biotech, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q3 2024
- Shares held
- 207.5K
- +46.2K (+28.6%) vs. Q3 2024
- Total value
- $350.1K
- −$368.1K (−51.3%) vs. Q3 2024
- New holders
- 3
- 3 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CM Management, LLC | 110,000 | $184.8K | 0.17% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,944 | $69.6K | 0.00% | +40,944 | New |
| Geode Capital Management, LLC | 19,804 | $33.7K | 0.00% | −1,005−4.8% | Reduced |
| Vanguard Group Inc | 15,864 | $27.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 15,313 | $25.7K | 0.00% | +15,313 | New |
| Tower Research Capital LLC (TRC) | 3,438 | $5.78K | 0.00% | +2,422+238.4% | Added |
| Royal Bank of Canada | 1,816 | $3.00K | 0.00% | +79+4.5% | Added |
| TD Waterhouse Canada Inc. | 142 | $236 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 100 | $168 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 31 | $52 | 0.00% | +27+675.0% | Added |
| Global Retirement Partners, LLC | 25 | $42 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19 | $32 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14 | $24 | 0.00% | −14−50.0% | Reduced |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 1 | $2 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% | +1 | New |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −8−100.0% | Sold out |